Review: Cancer Modeling

Slides:



Advertisements
Similar presentations
A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates Peter Calabrese & Darryl Shibata Question: A fundamental.
Advertisements

Cancer—Principles and overview By Robert A. Weinberg
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Using Parallel Genetic Algorithm in a Predictive Job Scheduling
Environmental vs demographic variability in stochastic lattice predator-prey models STATPHYS 25, Seoul, 25 July 2013 Ulrich Dobramysl & Uwe C. Täuber Department.
 Read Chapter 6 of text  Brachydachtyly displays the classic 3:1 pattern of inheritance (for a cross between heterozygotes) that mendel described.
PROLIFERAZIONE CELLULARE E RESISTENZA AI FARMACI.
Non-Linear Problems General approach. Non-linear Optimization Many objective functions, tend to be non-linear. Design problems for which the objective.
02/03/07DePaul University, HON2071 Evolutionary Computation Module for HON207.
What is Evolution? Variation exists in all populations Variation is inherited Evolution is heritable changes in a population over many generations. Descent.
1 Lecture 8: Genetic Algorithms Contents : Miming nature The steps of the algorithm –Coosing parents –Reproduction –Mutation Deeper in GA –Stochastic Universal.
Evolution of Cancer Rebellion within the cell clone collective.
Natalia Komarova (University of California - Irvine) Somatic evolution and cancer.
The Challenges of Making a Living. Learning Objectives 1.Review the levels of organization in living things, the importance of homeostasis, & how this.
Joanne Turner 15 Nov 2005 Introduction to Cellular Automata.
EVOLUTION. EVOLUTION The first living organisms were simple, single celled organisms. Through time more complex simple- celled creatures were created.
Evolution “On the origin of species” Charles Darwin 1859 Human evolution Evolution of antibacterial resistance.
Tumor genetics Minna Thullberg
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Chapter & 11.3.
- any detectable change in DNA sequence eg. errors in DNA replication/repair - inherited ones of interest in evolutionary studies Deleterious - will be.
Diseases of aging A&S Jim Lund There is still no cure for the common birthday. -John Glenn Assigned reading: Chapter 8, Handbook of Aging 5th ed.
The Mechanics of Evolution Interaction of Natural Selection and Inheritance (Genetics)
GOD-TALK.com Topic #7: What is Cancer? How does it fit into God’s creation? Dr. Andy and Doug A ROCKET SCIENTIST & ER DOCTOR/MINISTER DISCUSS SCIENCE &
1 Random Genetic Drift : Chance as an Evolutionary Force Random Genetic Drift is the random change in allele frequencies from one generation to the next.
Population genetics Evolution in more detail Populations Group of individuals of the same species in a given area All of the genes in a population =
Dr Gihan E-H Gawish, MSc, PhD Molecular Biology and Clinical Biochemistry KSU Cytogenetics Understanding the Disease Progression Process, Classical and.
Genetic algorithms Prof Kang Li
Evolutionary Graph Theory. Uses of graphical framework Graph can represent relationships in a social network of humans E.g. “Six degrees of separation”
Boltzmann Machine (BM) (§6.4) Hopfield model + hidden nodes + simulated annealing BM Architecture –a set of visible nodes: nodes can be accessed from outside.
Mutations.
What is a QUASI-SPECIES By Ye Dan U062281A USC3002 Picturing the World through Mathematics.
By the end of this lecture, students will learn: 1.What is cancer. 2.Genetics of cancer. 3.Oncogenes 4.Tumor suppressor genes. 5.DNA Repair genes 6.Genes.
AP Biology Evolution of Populations AP Biology Populations evolve  Natural selection acts on individuals  differential survival  “survival.
Chapter 21 The Mechanics of Evolution Biology 101 Tri-County Technical College Pendleton, SC.
Remainder of Chapter 23 Read the remaining materials; they address information specific to understanding evolution (e.g., variation and nature of changes)
Benign Versus Malignant Tumors
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Genes and Development Chapter 16. Development All the changes that occur during an organism’s lifetime Cell specialization: Cell determination: specific.
MISCONCEPTIONS ABOUT EVOLUTION BY NATURAL SELECTION
Stochastic models of evolution driven by Spatial Heterogeneity R H, Utrecht University, Department of Biology, Theoretical Biology Group.
Genome Evolution. Amos Tanay 2010 Genome evolution Lecture 4: population genetics III: selection.
Cancer Chapter 4 Supplement. Cancer - important facts Cancer is uncontrolled cell growth It requires several steps to form It is very different depending.
PHL 472 Chemical Carcinogens Abdelkader Ashour, Ph.D. 2 nd Lecture.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Objectives: 1)Describe how natural variation is used in artificial selection. 2)Explain how natural selection is related to species’ fitness. 3)Identify.
Neural Networks And Its Applications By Dr. Surya Chitra.
UNIVERSITA’ DEGLI STUDI NAPOLI FEDERICO II DOTTORATO IN INGEGNERIA DEI MATERIALI E DELLE STRUTTURE Brunella Corrado Filomena Gioiella Bernadette Lombardi.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
LECTURE 9. Genetic drift In population genetics, genetic drift (or more precisely allelic drift) is the evolutionary process of change in the allele frequencies.
Evolution of Cancer Rebellion within the cell clone collective.
What is Evolution??? Learning Target: I can explain Natural Selection and the 4 conditions that are required for Natural Selection to take place.
GENETIC BASIS OF CANCER
A Stochastic Model of Cell Differentiation
Intro to microbial evolution
CANCER.
Cancer as a genetic disease
The Theories of Evolution
Chapter 15: How Organisms Evolve.
Extracellular Regulation of Apoptosis
In your own words, explain the significance of the diagram shown.
EVOLUTION: DARWIN vs. LAMARCK
Introduction to Evolution
Stem Cell Heterogeneity and Plasticity in Epithelia
Boltzmann Machine (BM) (§6.4)
Cancer Lecture 42 BSCI 420,421,620 Dec 11, 2002
Local Regulation of Homeostasis Favors Chromosomal Instability
SURVIVAL OF THE FITTEST
Biomechanical force may promote tumor progression by establishing an aggressive tumor cell hierarchy. Biomechanical force may promote tumor progression.
Heterogeneity origins and maintenance.
Presentation transcript:

Review: Cancer Modeling Natalia Komarova (University of California - Irvine)

Plan Introduction: The concept of somatic evolution Loss-of-function and gain-of-function mutations Mass-action modeling Spatial modeling Hierarchical modeling Consequences from the point of view of tissue architecture and homeostatic control

Darwinian evolution (of species) Time-scale: hundreds of millions of years Organisms reproduce and die in an environment with shared resources

Darwinian evolution (of species) Time-scale: hundreds of millions of years Organisms reproduce and die in an environment with shared resources Inheritable germline mutations (variability) Selection (survival of the fittest)

Somatic evolution Cells reproduce and die inside an organ of one organism Time-scale: tens of years

Somatic evolution Cells reproduce and die inside an organ of one organism Time-scale: tens of years Inheritable mutations in cells’ genomes (variability) Selection (survival of the fittest)

Cancer as somatic evolution Cells in a multicellular organism have evolved to co-operate and perform their respective functions for the good of the whole organism

Cancer as somatic evolution Cells in a multicellular organism have evolved to co-operate and perform their respective functions for the good of the whole organism A mutant cell that “refuses” to co-operate may have a selective advantage

Cancer as somatic evolution Cells in a multicellular organism have evolved to co-operate and perform their respective functions for the good of the whole organism A mutant cell that “refuses” to co-operate may have a selective advantage The offspring of such a cell may spread

Cancer as somatic evolution Cells in a multicellular organism have evolved to co-operate and perform their respective functions for the good of the whole organism A mutant cell that “refuses” to co-operate may have a selective advantage The offspring of such a cell may spread This is a beginning of cancer

Progression to cancer

Progression to cancer Constant population

Progression to cancer Advantageous mutant

Progression to cancer Clonal expansion

Progression to cancer Saturation

Progression to cancer Advantageous mutant

Progression to cancer Wave of clonal expansion

Genetic pathways to colon cancer (Bert Vogelstein) “Multi-stage carcinogenesis”

Methodology: modeling a colony of cells Cells can divide, mutate and die

Methodology: modeling a colony of cells Cells can divide, mutate and die Mutations happen according to a “mutation-selection diagram”, e.g. u1 u2 u3 u4 (1) (r1) (r2) (r3) (r4)

Mutation-selection network (1) (r1) (r4) (r6) u2 u2 u5 u8 (r1) (r5) (r7)

Common patterns in cancer progression Gain-of-function mutations Loss-of-function mutations

Gain-of-function mutations Oncogenes K-Ras (colon cancer), Bcr-Abl (CML leukemia) Increased fitness of the resulting type Wild type Oncogene u (1) (r)

Loss-of-function mutations Tumor suppressor genes APC (colon cancer), Rb (retinoblastoma), p53 (many cancers) Neutral or disadvantageous intermediate mutants Increased fitness of the resulting type Wild type TSP+/+ TSP+/- TSP-/- u u x x x (1) (r<1) (R>1)

Stochastic dynamics on a selection-mutation network Given a selection-mutation diagram Assume a constant population with a cellular turn-over Define a stochastic birth-death process with mutations Calculate the probability and timing of mutant generation

Gain-of-function mutations Selection-mutation diagram: Number of is i u (1) (r ) Number of is j=N-i Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Start from only one cell of the second type; Suppress further mutations. What is the chance that it will take over? Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Start from only one cell of the second type. What is the chance that it will take over? If r=1 then = 1/N If r<1 then < 1/N If r>1 then > 1/N If r then = 1 Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Start from zero cell of the second type. What is the expected time until the second type takes over? Fitness = 1 Fitness = r >1

Evolutionary selection dynamics Start from zero cell of the second type. What is the expected time until the second type takes over? In the case of rare mutations, we can show that Fitness = 1 Fitness = r >1

Loss-of-function mutations (1) (r) (a) What is the probability that by time t a mutant of has been created? Assume that and

1D Markov process j is the random variable, If j = 1,2,…,N then there are j intermediate mutants, and no double-mutants If j=E, then there is at least one double-mutant j=E is an absorbing state

Transition probabilities

A two-step process

A two-step process

A two step process … …

A two-step process (1) (r) (a) Scenario 1: gets fixated first, and then a mutant of is created; Number of cells time

Stochastic tunneling …

Stochastic tunneling (1) (r) (a) Scenario 2: A mutant of is created before reaches fixation Number of cells time

The coarse-grained description Long-lived states: x0 …“all green” x1 …“all blue” x2 …“at least one red”

Stochastic tunneling Assume that and Neutral intermediate mutant Disadvantageous intermediate mutant Assume that and

The mass-action model is unrealistic All cells are assumed to interact with each other, regardless of their spatial location All cells of the same type are identical

The mass-action model is unrealistic All cells are assumed to interact with each other, regardless of their spatial location Spatial model of cancer All cells of the same type are identical

The mass-action model is unrealistic All cells are assumed to interact with each other, regardless of their spatial location Spatial model of cancer All cells of the same type are identical Hierarchical model of cancer

Spatial model of cancer Cells are situated in the nodes of a regular, one-dimensional grid A cell is chosen randomly for death It can be replaced by offspring of its two nearest neighbors

Spatial dynamics

Spatial dynamics

Spatial dynamics

Spatial dynamics

Spatial dynamics

Spatial dynamics

Spatial dynamics

Spatial dynamics

Spatial dynamics

Gain-of-function: probability to invade In the spatial model, the probability to invade depends on the spatial location of the initial mutation

Probability of invasion Neutral mutants, r = 1 Advantageous mutants, r = 1.2 Mass-action Disadvantageous mutants, r = 0.95 Spatial

Use the periodic boundary conditions Mutant island

Probability to invade For disadvantageous mutants For neutral mutants For advantageous mutants

Loss-of-function mutations (1) (r) (a) What is the probability that by time t a mutant of has been created? Assume that and

Transition probabilities No double-mutants, j intermediate cells At least one double-mutant Mass-action Space

Stochastic tunneling

Stochastic tunneling Slower

Stochastic tunneling Slower Faster

The mass-action model is unrealistic All cells are assumed to interact with each other, regardless of their spatial location Spatial model of cancer All cells of the same type are identical Hierarchical model of cancer P

Hierarchical model of cancer

Colon tissue architecture

Colon tissue architecture Crypts of a colon

Colon tissue architecture Crypts of a colon

Cancer of epithelial tissues Gut Cells in a crypt of a colon

Cancer of epithelial tissues Cells in a crypt of a colon Gut Stem cells replenish the tissue; asymmetric divisions

Cancer of epithelial tissues Cells in a crypt of a colon Gut Proliferating cells divide symmetrically and differentiate Stem cells replenish the tissue; asymmetric divisions

Cancer of epithelial tissues Cells in a crypt of a colon Gut Differentiated cells get shed off into the lumen Proliferating cells divide symmetrically and differentiate Stem cells replenish the tissue; asymmetric divisions

Finite branching process

Cellular origins of cancer Gut If a stem cell tem cell acquires a mutation, the whole crypt is transformed

Cellular origins of cancer Gut If a daughter cell acquires a mutation, it will probably get washed out before a second mutation can hit

Colon cancer initiation

Colon cancer initiation

Colon cancer initiation

Colon cancer initiation

Colon cancer initiation

Colon cancer initiation

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

First mutation in a daughter cell

Two-step process and tunneling time Number of cells First hit in the stem cell Second hit in a daughter cell Number of cells First hit in a daughter cell time

Stochastic tunneling in a hierarchical model

Stochastic tunneling in a hierarchical model The same

Stochastic tunneling in a hierarchical model The same Slower

The mass-action model is unrealistic All cells are assumed to interact with each other, regardless of their spatial location Spatial model of cancer All cells of the same type are identical Hierarchical model of cancer P P

Comparison of the models Probability of mutant invasion for gain-of-function mutations r = 1 neutral

Comparison of the models The tunneling rate (lowest rate)

The tunneling and two-step regimes

Production of double-mutants Population size Small Large Interm. mutants Neutral (mass-action, spatial and hierarchical) All models give the same results Spatial model is the fastest Hierarchical model is the slowest Disadvantageous (mass-action and Spatial only) Spatial model is the fastest Mass-action model is faster Spatial model is slower

Production of double-mutants Population size Small Large Interm. mutants Neutral (mass-action, spatial and hierarchical) All models give the same results Spatial model is the fastest Hierarchical model is the slowest Disadvantageous (mass-action and Spatial only) Spatial model is the fastest Mass-action model is faster Spatial model is slower

The definition of “small” 1000 r=1 Spatial model is the fastest r=0.99 500 r=0.95 r=0.8 1 2 3 4 5 6 7 8 9

Summary The details of population modeling are important, the simple mass-action can give wrong predictions

Summary The details of population modeling are important, the simple mass-action can give wrong predictions Different types of homeostatic control have different consequence in the context of cancerous transformation

Summary If the tissue is organized into compartments with stem cells and daughter cells, the risk of mutations is lower than in homogeneous populations

Summary If the tissue is organized into compartments with stem cells and daughter cells, the risk of mutations is lower than in homogeneous populations For population sizes greater than 102 cells, spatial “nearest neighbor” model yields the lowest degree of protection against cancer

Summary A more flexible homeostatic regulation mechanism with an increased cellular motility will serve as a protection against double-mutant generation

Conclusions Main concept: cancer is a highly structured evolutionary process Main tool: stochastic processes on selection-mutation networks We studied the dynamics of gain-of-function and loss-of-function mutations There are many more questions in cancer research…